04.30.24 -- Managing Supply Chain Risks Using Relational Risk Analysis

With the European Union's Medical Devices Regulation now in full effect, manufacturers face the imperative task of comprehending and adhering to its stipulations.

The unique demands of remote work can require institutions to fundamentally change their organizational structure to empower the use of remote work tools and strategies.

By partnering with a CDMO with experience in pediatric formulation, pharmaceutical companies can increase the acceptability of their drugs among pediatric patients.

The formulation and manufacture of modified-release OSD forms are highly specialized. Review considerations for planning and executing a successful modified release oral solid dosage formulation.

Explore study findings on a validated LC–MS/MS method for quantifying copanlisib from a mouse dried blood spot and its potential for enabling desirable sensitivity, accuracy, and precision.

Everything from glass or plastic bottles to the ink used in labels can leach unwanted contaminants. The first challenge chemists address is to narrow the focus on the most likely suspects.

Learn how a CDMO that is experienced in producing and characterizing diverse recombinant proteins is essential when accelerating the successful transfer of recombinant protein analytical assays.

Begin your antibody drug conjugate manufacturing journey by finding a partner that can provide support through every phase of the conjugate life cycle, including process optimization, scale-up, and validation.

Optimizing delivery along with the formulation is the key to successful clinical outcomes. Research is necessary to understand the relationship between body morphology, injection force, and needle length.

Challenges specific to eye physiology complicate new therapy development and necessitate innovative drug delivery methods. Biodegradable polymers show promise in addressing these challenges.

Learn about a platform for creating injectable and implantable long-acting drug delivery products, including its technical basics and how it can be used to deliver small molecules, peptides, and biologics.

A CDMO can augment your capacity and expertise, refine your processes, and ultimately shorten your time to market. Explore best practices that make working with a CDMO as efficient as possible.

Discover how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.

Achilles Therapeutics sources a customized aseptic processing solution to safely process irreplaceable personalized T-cell therapies.

Experts from Ajinomoto Bio-Pharma Services explore the necessary components of a tech transfer for LNP-based drugs, including the outsourcing strategies needed to avoid pitfalls.